Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Cliff

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMJ Open Respiratory Research|August 7, 2021
Can categorised values of maximal oxygen uptake discriminate patterns of exercise dysfunction in pectus excavatum: a prospective cohort study?Christopher M R Satur, Ian Cliff, Nicholas Watson
BMJ Leader|September 28, 2022
Impact of the COVID-19 pandemic on a respiratory physiology department and the patient's perception of rapid service changeIan Cliff, Naveed Mustfa, Imran Hussain, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
Efficacy of continuous positive airway pressure in casualties suffering from primary blast lung injury: A modeling studyTimothy E Scott, Mainul Haque, Anup Das, et al.
Respiratory Medicine|February 8, 2018
Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD)Shaney L Barratt, Jonathon Shaw, Rachel Jones, et al.
European Journal of Pediatrics|January 13, 2011
Respiratory morbidity, healthcare utilisation and cost of care at school age related to home oxygen statusAnne Greenough, John Alexander, Jill Boorman, et al.
BMJ Open Respiratory Research|July 8, 2020
ARTP statement on pulmonary function testing 2020Karl Peter Sylvester, Nigel Clayton, Ian Cliff, et al.
European Journal of Pharmacology|June 15, 2010
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetesShuchita Singh, Subhasis Roy, Sachin Sethi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMJ Open Respiratory Research|August 7, 2021
Can categorised values of maximal oxygen uptake discriminate patterns of exercise dysfunction in pectus excavatum: a prospective cohort study?Christopher M R Satur, Ian Cliff, Nicholas Watson
BMJ Leader|September 28, 2022
Impact of the COVID-19 pandemic on a respiratory physiology department and the patient's perception of rapid service changeIan Cliff, Naveed Mustfa, Imran Hussain, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
Efficacy of continuous positive airway pressure in casualties suffering from primary blast lung injury: A modeling studyTimothy E Scott, Mainul Haque, Anup Das, et al.
Respiratory Medicine|February 8, 2018
Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD)Shaney L Barratt, Jonathon Shaw, Rachel Jones, et al.
European Journal of Pediatrics|January 13, 2011
Respiratory morbidity, healthcare utilisation and cost of care at school age related to home oxygen statusAnne Greenough, John Alexander, Jill Boorman, et al.
BMJ Open Respiratory Research|July 8, 2020
ARTP statement on pulmonary function testing 2020Karl Peter Sylvester, Nigel Clayton, Ian Cliff, et al.
European Journal of Pharmacology|June 15, 2010
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetesShuchita Singh, Subhasis Roy, Sachin Sethi, et al.
Pageof 1